Outcomes and Safety of History-Based Screening for Medication Abortion
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Internal Medicine"
DOI: 10.1001/jamainternmed.2022.0217
Abstract: This cohort study evaluates the outcomes and safety of a history-based screening, no-test approach to medication abortion care. read more here.
Keywords: medication abortion; history based; safety history; based screening ... See more keywords
Association of Texas Senate Bill 8 With Requests for Self-managed Medication Abortion
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.1122
Abstract: This cross-sectional study examines whether the passage of Texas Senate Bill 8 was associated with an increase in requests for self-managed medication abortion. read more here.
Keywords: texas senate; medication abortion; requests self; managed medication ... See more keywords
Changes in Support for Advance Provision and Over-the-Counter Access to Medication Abortion
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.54767
Abstract: This cross-sectional study evaluates changes in national support for and personal interest in advance provision and over-the-counter access to medication abortion in the US since the Dobbs v Jackson Women’s Health Supreme Court decision. read more here.
Keywords: counter access; access medication; advance provision; provision counter ... See more keywords
Willingness of Pharmacists to Prescribe Medication Abortion in California
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.6018
Abstract: Key Points Question Are pharmacists in California willing to prescribe medication abortion? Findings In this cross-sectional survey study of 316 California community pharmacists, 193 of 280 (69%) were willing to prescribe medication abortion if permitted… read more here.
Keywords: prescribe medication; medication abortion; willingness; california ... See more keywords
Contraception after medication abortion in the United States: results from a cluster randomized trial
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2017.09.020
Abstract: BACKGROUND: Understanding how contraceptive choices and access differ for women having medication abortions compared to aspiration procedures can help to identify priorities for improved patient‐centered postabortion contraceptive care. OBJECTIVE: The objective of this study was… read more here.
Keywords: aspiration abortion; abortion; medication abortion; medication ... See more keywords
Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: a retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador.
Sign Up to like & getrecommendations! Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.04.015
Abstract: OBJECTIVES In settings where abortion is legally restricted or inaccessible, grassroots feminist networks provide evidence-based information and support to individuals who self-manage abortions-a model of care known as abortion accompaniment. This study aims to fill… read more here.
Keywords: accompaniment; abortion; weeks gestation; medication abortion ... See more keywords
Auricular acupressure and acupuncture as adjuncts for pain management during first trimester medication abortion: a randomized three-arm trial.
Sign Up to like & getrecommendations! Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.12.003
Abstract: OBJECTIVES To measure pain during first trimester medication abortion using auricular acupressure or auricular acupuncture as an adjunct to pain management. We measured anxiety as a secondary outcome. STUDY DESIGN This randomized, double-blinded, three-arm trial… read more here.
Keywords: acupressure; auricular acupressure; medication abortion; acupuncture ... See more keywords
Provision of medication abortion in Hawai‘i during COVID-19: Practical experience with multiple care delivery models
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.03.025
Abstract: Objective : To demonstrate the effectiveness of medication abortion with the implementation of telemedicine and a no-test protocol in response to the COVID-19 pandemic. Study design : This is a retrospective cohort study of patients… read more here.
Keywords: care delivery; abortion; medication abortion; hawai ... See more keywords
Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.03.026
Abstract: OBJECTIVE To estimate obstetrician-gynecologists' (ob-gyns) willingness to provide medication abortion if the in-person dispensing requirement for mifepristone were removed. STUDY DESIGN We analyzed a subsample (n=868) from a 2016-2017 national survey of ob-gyns, focusing on… read more here.
Keywords: abortion; dispensing requirement; medication abortion; person dispensing ... See more keywords
The Future of Abortion is Now: Mifepristone by Mail and In-Clinic Abortion Access in the United States.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.03.033
Abstract: The COVID-19 pandemic disrupted health care delivery in all aspects of medicine, including abortion care. For six months, the mifepristone Risk Evaluation and Mitigation strategy (REMS) was temporarily blocked, allowing for remote provision of medication… read more here.
Keywords: abortion; medication abortion; future abortion; care ... See more keywords
Exploring the impact of mifepristone's Risk Evaluation and Mitigation Strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics.
Sign Up to like & getrecommendations! Published in 2022 at "Contraception"
DOI: 10.1016/j.contraception.2022.01.017
Abstract: OBJECTIVES In 2000, the United States' Food and Drug Administration (FDA) approved mifepristone for medication abortion. In this article, we explore how the Risk Evaluation and Mitigation Strategy (REMS) criteria for mifepristone specifically impede family… read more here.
Keywords: abortion; family; medication abortion; primary care ... See more keywords